COMP <GO>
VNDA vs LFCR // PIOTROSKI F-SCORE QUALITY
Vanda Pharmaceuticals Inc. (NASDAQ) VS. Lifecore Biomedical Inc. (NASDAQ) • 15-METRIC TALLY: VNDA 0
— LFCR 2
■ METRIC PARITY
LAST: $4.05 (+1.25%) • MKT CAP: $244.9M
piotroski-score
3/9
LAST: $6.52 (+0.15%) • MKT CAP: $246.8M
piotroski-score
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VNDA VS. LFCR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VNDA | LFCR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 8.70% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 3/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 26.7 | 65.4 | -38.76 | LFCR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $244.9M | $246.8M | -$1.9M | LFCR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VNDA REV | LFCR REV | VNDA GROSS % | LFCR GROSS % | VNDA FCF | LFCR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $216.1M | $0 | — | — | -$110.4M | — |
| FY 2024 | $198.8M | $128.9M | — | 31.3% | -$16.2M | -$13.6M |
| FY 2023 | $192.6M | $0 | — | — | $12.8M | $257.0K |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VNDA // BETA —
LFCR // BETA —